Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMEPRAZOLE Cause Lung neoplasm malignant? 115 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Lung neoplasm malignant have been filed in association with OMEPRAZOLE (omeprazole sodium bicarbonate). This represents 0.1% of all adverse event reports for OMEPRAZOLE.

115
Reports of Lung neoplasm malignant with OMEPRAZOLE
0.1%
of all OMEPRAZOLE reports
64
Deaths
63
Hospitalizations

How Dangerous Is Lung neoplasm malignant From OMEPRAZOLE?

Of the 115 reports, 64 (55.7%) resulted in death, 63 (54.8%) required hospitalization, and 50 (43.5%) were considered life-threatening.

Is Lung neoplasm malignant Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMEPRAZOLE. However, 115 reports have been filed with the FAERS database.

What Other Side Effects Does OMEPRAZOLE Cause?

Chronic kidney disease (35,759) Acute kidney injury (19,260) Renal failure (14,721) End stage renal disease (10,356) Renal injury (9,482) Tubulointerstitial nephritis (4,809) Drug ineffective (4,355) Gastrooesophageal reflux disease (3,929) Pain (3,602) Nephrogenic anaemia (2,873)

What Other Drugs Cause Lung neoplasm malignant?

RANITIDINE (15,214) ADALIMUMAB (698) TIOTROPIUM (637) ETANERCEPT (612) METHOTREXATE (522) CLOZAPINE (440) APIXABAN (411) ALBUTEROL (403) INFLIXIMAB (379) BUDESONIDE\FORMOTEROL (353)

Which OMEPRAZOLE Alternatives Have Lower Lung neoplasm malignant Risk?

OMEPRAZOLE vs OMEPRAZOLE\SODIUM BICARBONATE OMEPRAZOLE vs OMNIPAQUE OMEPRAZOLE vs OMNISCAN OMEPRAZOLE vs ONABOTULINUMTOXINA OMEPRAZOLE vs ONASEMNOGENE ABEPARVOVEC

Related Pages

OMEPRAZOLE Full Profile All Lung neoplasm malignant Reports All Drugs Causing Lung neoplasm malignant OMEPRAZOLE Demographics